Skip to content
OpenCapital
Get started

Profound Medical PROF Accrued Progress Collections and Price Adjustments

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K—
Free cash flow-$9.6M—

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%—

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's accrued progress collections and price adjustments.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's accrued progress collections and price adjustments?
Profound Medical (PROF) reported accrued progress collections and price adjustments of $441K in Q1 2026.
How has Profound Medical's accrued progress collections and price adjustments changed year-over-year?
Profound Medical's accrued progress collections and price adjustments increased by 418.8% year-over-year, from $85K to $441K.
What is the long-term trend for Profound Medical's accrued progress collections and price adjustments?
Over 2 years (2023 to 2025), Profound Medical's accrued progress collections and price adjustments has grown at a -27.0% compound annual growth rate (CAGR), from $728K to $388K.